相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Cancer statistics, 2020
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2020)
Pan-cancer analysis of whole genomes
Peter J. Campbell et al.
NATURE (2020)
Neoadjuvant checkpoint blockade for cancer immunotherapy
Suzanne L. Topalian et al.
SCIENCE (2020)
VISTA is a checkpoint regulator for naive T cell quiescence and peripheral tolerance
Mohamed A. ElTanbouly et al.
SCIENCE (2020)
Interrogation of the Microenvironmental Landscape in Brain Tumors Reveals Disease-Specific Alterations of Immune Cells
Florian Klemm et al.
CELL (2020)
Understanding the glioblastoma immune microenvironment as basis for the development of new immunotherapeutic strategies
Ana Rita Pombo Antunes et al.
ELIFE (2020)
T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment
Mei-Chun Cai et al.
JOURNAL OF PATHOLOGY (2020)
Neutrophil extracellular traps mediate the crosstalk between glioma progression and the tumor microenvironment via the HMGB1/RAGE/IL-8 axis
Caijun Zha et al.
CANCER BIOLOGY & MEDICINE (2020)
DNA damage repair alterations modulate M2 polarization of microglia to remodel the tumor microenvironment via the p53-mediated MDK expression in glioma
Xiangqi Meng et al.
EBIOMEDICINE (2019)
Immunogenomic analysis reveals LGALS1 contributes to the immune heterogeneity and immunosuppression in glioma
Qun Chen et al.
INTERNATIONAL JOURNAL OF CANCER (2019)
Correlate the TP53 Mutation and the HRAS Mutation with Immune Signatures in Head and Neck Squamous Cell Cancer
Haoyu Lyu et al.
COMPUTATIONAL AND STRUCTURAL BIOTECHNOLOGY JOURNAL (2019)
A transcriptionally and functionally distinct PD-1+ CD8+ T cell pool with predictive potential in non-small-cell lung cancer treated with PD-1 blockade
Daniela S. Thommen et al.
NATURE MEDICINE (2018)
Current state of immunotherapy for glioblastoma
Michael Lim et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2018)
A Comprehensive Immunologic Portrait of Triple-Negative Breast Cancer
Zhixian Liu et al.
TRANSLATIONAL ONCOLOGY (2018)
Modeling tumor immunity of mouse glioblastoma by exhausted CD8+ T cells
Hiroshi Nakashima et al.
SCIENTIFIC REPORTS (2018)
Immune heterogeneity and clinicopathologic characterization of IGFBP2 in 2447 glioma samples
Jinquan Cai et al.
ONCOIMMUNOLOGY (2018)
Immunogenomics Analysis Reveals that TP53 Mutations Inhibit Tumor Immunity in Gastric Cancer
Zehang Jiang et al.
TRANSLATIONAL ONCOLOGY (2018)
A Paradigm Shift in Cancer Immunotherapy: From Enhancement to Normalization
Miguel F. Sanmamed et al.
CELL (2018)
Maftools: efficient and comprehensive analysis of somatic variants in cancer
Anand Mayakonda et al.
GENOME RESEARCH (2018)
Targeting glioma stem cells through combined BMI1 and EZH2 inhibition
Xun Jin et al.
NATURE MEDICINE (2017)
Tumour-associated macrophages as treatment targets in oncology
Alberto Mantovani et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2017)
Tumor Mutational Burden and Response Rate to PD-1 Inhibition
Mark Yarchoan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Molecular and clinical characterization of TIM-3 in glioma through 1,024 samples
Guanzhang Li et al.
ONCOIMMUNOLOGY (2017)
Macrophage Polarization Contributes to Glioblastoma Eradication by Combination Immunovirotherapy and Immune Checkpoint Blockade
Dipongkor Saha et al.
CANCER CELL (2017)
CGCG clinical practice guidelines for the management of adult diffuse gliomas
Tao Jiang et al.
CANCER LETTERS (2016)
A Landscape of Pharmacogenomic Interactions in Cancer
Francesco Iorio et al.
CELL (2016)
Genomic and Transcriptomic Features of Response to Anti-PD-1 Therapy in Metastatic Melanoma
Willy Hugo et al.
CELL (2016)
Defining CD8+ T cells that provide the proliferative burst after PD-1 therapy
Se Jin Im et al.
NATURE (2016)
Molecular and clinical characterization of PD-L1 expression at transcriptional level via 976 samples of brain glioma
Zheng Wang et al.
OncoImmunology (2016)
Comprehensive analyses of tumor immunity: implications for cancer immunotherapy
Bo Li et al.
GENOME BIOLOGY (2016)
Chemical compounds from anthropogenic environment and immune evasion mechanisms: potential interactions
Julia Kravchenko et al.
CARCINOGENESIS (2015)
Structural and functional features of central nervous system lymphatic vessels
Antoine Louveau et al.
NATURE (2015)
Robust enumeration of cell subsets from tissue expression profiles
Aaron M. Newman et al.
NATURE METHODS (2015)
Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors
Jeanette E. Eckel-Passow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
circlize implements and enhances circular visualization in R
Zuguang Gu et al.
BIOINFORMATICS (2014)
Clinical drug response can be predicted using baseline gene expression levels and in vitro drug sensitivity in cell lines
Paul Geeleher et al.
GENOME BIOLOGY (2014)
GSVA: gene set variation analysis for microarray and RNA-Seq data
Sonja Haenzelmann et al.
BMC BIOINFORMATICS (2013)
Prognostically relevant gene signatures of high-grade serous ovarian carcinoma
Roel G. W. Verhaak et al.
JOURNAL OF CLINICAL INVESTIGATION (2013)
Genomics of Drug Sensitivity in Cancer (GDSC): a resource for therapeutic biomarker discovery in cancer cells
Wanjuan Yang et al.
NUCLEIC ACIDS RESEARCH (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
Relationship between Tumor Enhancement, Edema, IDH1 Mutational Status, MGMT Promoter Methylation, and Survival in Glioblastoma
J. A. Carrillo et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2012)
PPAR-γ is a major driver of the accumulation and phenotype of adipose tissue Treg cells
Daniela Cipolletta et al.
NATURE (2012)
Bat3 promotes T cell responses and autoimmunity by repressing Tim-3-mediated cell death and exhaustion
Manu Rangachari et al.
NATURE MEDICINE (2012)
IL-10 Elicits IFNγ-Dependent Tumor Immune Surveillance
John B. Mumm et al.
CANCER CELL (2011)
Integrated Genomic Analysis Identifies Clinically Relevant Subtypes of Glioblastoma Characterized by Abnormalities in PDGFRA, IDH1, EGFR, and NF1
Roel G. W. Verhaak et al.
CANCER CELL (2010)
Normal human monocytes exposed to glioma cells acquire myeloid-derived suppressor cell-like properties
Jennifer C. Rodrigues et al.
NEURO-ONCOLOGY (2010)
Genetic signature of adult gliomas and correlation with MRI features
Maria Grazia Bruzzone et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2009)
Circos: An information aesthetic for comparative genomics
Martin Krzywinski et al.
GENOME RESEARCH (2009)
Comprehensive genomic characterization defines human glioblastoma genes and core pathways
L. Chin et al.
NATURE (2008)
Loss of tumor suppressor PTEN function increases B7-H1 expression and immunoresistance in glioma
Andrew T. Parsa et al.
NATURE MEDICINE (2007)
Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles
A Subramanian et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Dendritic cells permit immune invasion of the CNS in an animal model of multiple sclerosis
M Greter et al.
NATURE MEDICINE (2005)
Two-dimensional PCA: A new approach to appearance-based face representation and recognition
J Yang et al.
IEEE TRANSACTIONS ON PATTERN ANALYSIS AND MACHINE INTELLIGENCE (2004)
A functional role of HLA-G expression in human gliomas: An alternative strategy of immune escape
H Wiendl et al.
JOURNAL OF IMMUNOLOGY (2002)
Apoptosis of T lymphocytes invading glioblastomas multiforme: a possible tumor defense mechanism
VV Didenko et al.
JOURNAL OF NEUROSURGERY (2002)
分享论文
